BioSpace News Archive

Drug Development

Intellia’s CRISPR Trial Delay Raises Questions About Immune Responses

In its recent third-quarter report, Cambridge, Mass.-based Intellia Therapeutics indicated it is delaying its submission of an Investigational New Drug (IND) application until 2020, from late 2019.

November 1, 2018
·
3 min read
·
Mark Terry
Deals

Illumina Acquires Pacific Biosciences for $1.2 Billion

The deal to acquire its rival, Pacific Biosciences, will provide Illumina with a more comprehensive sequencing test at a lower cost.

November 1, 2018
·
2 min read
·
Alex Keown
Business

CuraSen Therapeutics Expands Management Team; Industry Veteran and Neuroscience Expert Gabriel Vargas, MD, PhD, Appointed to Chief Medical Officer

CuraSen Therapeutics, Inc. today announced that it has appointed Gabriel Vargas, MD, PhD, as chief medical officer. Dr. Vargas brings to CuraSen more than 12 years of experience in early drug development and neuroscience expertise.

November 1, 2018
·
2 min read
BioMidwest

Osprey Medical Announces Capital Raising of US$14.5M to Accelerate US and International Growth

US$7m private placement to Allan Gray at an issue price of US$0.11 per CDI

November 1, 2018
·
8 min read
Drug Development

SanBio Announces Phase 2 STEMTRA Trial Using SB623 Cells for Treatment of Patients with Traumatic Brain Injury Met Primary Endpoint

The SanBio Group announces today that the Phase 2 STEMTRA trial using SB623 cells for the treatment of patients with traumatic brain injury (TBI), met its primary endpoint.

November 1, 2018
·
1 min read
Breast Aesthetics Company POLYTECH Reveals New Brand Identity at ISAPS Congress, Focusing on Translating Quality Standards Into a Tangible Experience

POLYTECH Health & Aesthetics GmbH, an international leader in Breast Aesthetics, announced today the launch of the new POLYTECH company branding and a new company website.

November 1, 2018
·
3 min read
Job Trends

Approximately 1 in 3 Adults with Diabetes May Develop Chronic Kidney Disease

DaVita raises awareness about link between diabetes and CKD during National Diabetes Awareness Month

November 1, 2018
·
3 min read
Business

IDEXX Laboratories Announces Third Quarter 2018 Results

Reports revenue growth of 11% on a reported basis and 12% on an organic basis, driven by CAG Diagnostics recurring revenue growth of 12% reported and 13% organic

November 1, 2018
·
31 min read
Business

Teleflex Reports Third Quarter 2018 Results

Third Quarter Revenues of $609.7 million, up 14.0% Versus Prior Year Period; up 15.0% on Constant Currency Basis

November 1, 2018
·
35 min read
Business

Eagle Pharmaceuticals, Inc. Reports Third Quarter 2018 Results

Q3 2018 net income was $0.94 per basic and $0.91 per diluted share and adjusted non-GAAP net income was $1.22 per basic and $1.18 per diluted share

November 1, 2018
·
19 min read